Zentalis Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.4M | 293k | 15.15 |
| 2023-09-30 | $4.5M | 223k | 20.06 |
| 2023-06-30 | $21M | 734k | 28.21 |
| 2023-03-31 | $3.5M | 204k | 17.20 |
| 2022-12-31 | $7.9M | 390k | 20.14 |
| 2022-06-30 | $11M | 398k | 28.10 |
| 2022-03-31 | $12M | 265k | 46.14 |
| 2021-12-31 | $12M | 141k | 84.06 |
| 2021-09-30 | $15M | 230k | 66.64 |
| 2021-03-31 | $2.2M | 52k | 43.40 |
| 2020-12-31 | $12M | 224k | 51.94 |
| 2020-09-30 | $1.1M | 32k | 32.70 |
| 2020-06-30 | $664k | 14k | 48.05 |